2021 年疣治疗市场价值为 18.2954 亿美元,预计 2021 年至 2028 年的复合年增长率为 3.4%。
疣治疗市场的增长归因于人乳头瘤病毒感染和生殖器疣复发的不断增加以及新产品的开发。然而,低收入国家诊断情况不佳,限制了市场的增长。疣是由人乳头瘤病毒 (HPV) 引起的皮肤增生。HPV 有 60 多种,其中几种会导致皮肤上长疣。虽然局部治疗可能在几周内解决疣问题,副作用很小,但可能并非一直有效。因此,液氮冷冻疗法是一种合适的治疗选择,治愈率为 60-90%,复发率低于 10-20%。
在美国,由于重点转向 COVID-19,对疣治疗程序的需求有所减少。这场大流行给全球供应链、消费市场和整个经济造成了严重破坏。由于世界各国政府实施的措施对疣治疗市场的增长产生了负面影响。
定制此报告以满足您的需求
您可以免费定制任何报告,包括本报告的部分内容、国家级分析、Excel 数据包,以及为初创企业和大学提供优惠和折扣
- 获取此报告的关键市场趋势。这个免费样品将包括数据分析,从市场趋势到估计和预测。
市场洞察
人类乳头瘤病毒感染率上升和生殖器疣复发推动疣治疗市场增长
疣是由多种人类乳头瘤病毒 (HPV) 引起的,不同的病毒株会导致身体不同部位出现疣。健康人接触疣后就会感染。美国疾病控制与预防中心 (CDC) 的数据显示,2018 年美国约有 20% 的人口(即约 4,250 万人)患有性传播感染 (STI)。此外,在接种 HPV 疫苗之前,美国每年约有 34 万至 36 万男性和女性感染生殖器疣。而且,生殖器疣的复发率很高。美国国家生物技术信息中心 (NCBI) 的数据显示,全球约有 30% 的疣病例会在感染后的前四个月内消退。此外,HPV 感染会导致宫颈癌,而宫颈癌是全球女性中第四大常见癌症。根据世界卫生组织 (WHO) 的数据,2018 年记录了约 570,000 例宫颈癌新病例,低收入国家的发病率很高。因此,HPV 感染率的增加导致疣病例增加,而疣的高复发率正在推动疣治疗市场的增长。
基于类型的洞察
根据类型,疣治疗市场进一步细分为普通疣、生殖器疣、扁平疣和其他。普通疣细分市场占据最大的市场份额。然而,生殖器疣细分市场预计将在 2021-2028 年期间实现最高复合年增长率。生殖器疣是指通常由 HPV 引起的性传播感染。性传播疾病的流行率不断上升,以及开发生殖器疣治疗方案的研发力度不断加大,将推动未来几年该细分市场的市场增长。
基于治疗的见解
根据治疗方法,疣治疗市场进一步细分为物理破坏、免疫调节和化学破坏。物理破坏市场进一步细分为冷冻疗法、手术切除和激光治疗。免疫调节细分为干扰素、类视黄酸和锌。化学破坏细分进一步分为博来霉素、斑蝥素、水杨酸等。物理破坏细分在疣治疗市场中占有最大份额,预计在预测期内将实现市场最高复合年增长率。
基于最终用户的洞察
根据最终用户,疣治疗市场分为医院、家庭护理、专科诊所和其他。医院部分占有最大的市场份额。然而,预计家庭护理部分在预测期内的复合年增长率最高。该部分预计的市场增长可归因于全球医院数量的增加以及外科手术数量的快速增长。
疣治疗市场中的公司正在采用产品创新战略来满足全球不断变化的客户需求,这也使他们能够在全球市场上保持自己的品牌名称。
疣治疗市场区域洞察
Insight Partners 的分析师已详尽解释了预测期内影响疣治疗市场的区域趋势和因素。本节还讨论了北美、欧洲、亚太地区、中东和非洲以及南美和中美洲的疣治疗市场细分和地理位置。
- 获取疣治疗市场的区域特定数据
疣治疗市场报告范围
报告属性 | 细节 |
---|---|
2021 年市场规模 | 18.3亿美元 |
2028 年市场规模 | 23.1亿美元 |
全球复合年增长率(2021 - 2028) | 3.4% |
史料 | 2019-2020 |
预测期 | 2022-2028 |
涵盖的领域 | 按类型
|
覆盖地区和国家 | 北美
|
市场领导者和主要公司简介 |
|
市场参与者密度:了解其对商业动态的影响
疣治疗市场正在快速增长,这得益于终端用户需求的不断增长,这些需求源于消费者偏好的不断变化、技术进步以及对产品优势的认识不断提高等因素。随着需求的增加,企业正在扩大其产品范围,进行创新以满足消费者的需求,并利用新兴趋势,从而进一步推动市场增长。
市场参与者密度是指在特定市场或行业内运营的企业或公司的分布情况。它表明在给定市场空间中,相对于其规模或总市场价值,有多少竞争对手(市场参与者)存在。
在疣治疗市场运营的主要公司有:
- 博士伦保健公司
- 尼尔森生物科学公司
- 欧洲维塔尔制药有限公司
- 西普拉公司
- 荷兰皇家尤特莫伦有限公司
免责声明:上面列出的公司没有按照任何特定顺序排列。
- 获取疣治疗市场顶级关键参与者概述
疣治疗市场 – 按类型
- 普通疣
- 生殖器疣
- 扁平疣
- 其他的
疣治疗市场 – 按治疗方法
- 物理破坏
- 冷冻疗法
- 手术切除
- 激光治疗
- 免疫调节
- 干扰素
- 类视黄酸
- 锌
- 化学销毁
- 博来霉素
- 斑蝥素
- 水杨酸
- 其他的
疣治疗市场 – 按最终用户划分
- 医院
- 家庭护理
- 专科诊所
- 其他的
疣治疗市场——按地区划分
- 北美
- 我们
- 加拿大
- 墨西哥
- 欧洲
- 法国
- 德国
- 意大利
- 英国
- 西班牙
- 欧洲其他地区
- 亚太地区 (APAC)
- 中国
- 印度
- 韩国
- 日本
- 澳大利亚
- 亚太地区其他地区
- 中东和非洲 (MEA)
- 南非
- 沙特阿拉伯
- 阿联酋
- MEA 其他地区
- 南美洲和中美洲(SCAM)
- 巴西
- 阿根廷
- 其余的骗局
公司简介
- 博士伦保健公司
- 尼尔森生物科学公司
- 欧洲维塔尔制药有限公司
- 西普拉公司
- 荷兰皇家尤特莫伦有限公司
- Novan 公司
- Scholl 健康公司
- 梯瓦制药工业有限公司
- Verrica 制药公司
- 葛兰素史克公司
- AIM免疫技术公司
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The physical destruction segment is growing at the highest CAGR owing to availability of diagnostic devices and ease offered by these devices for diagnosis of various disorders.
Asia Pacific is expected to be the fastest growing region in the warts therapeutics market. The growth of the market in this region is primarily due to supportive government initiatives and research in the field of HPV infection.
North America dominates the global warts therapeutics market due to factors such as rising prevalence of HPV, increasing product launches, well-developed healthcare facility centres equipped with modern-age equipment and instruments.
Various companies have made organic growth strategies in the warts therapeutics market. Some of the activities undertaken by the company, which have promoted its growth are, launches, enhancements and expansion & relocation activities. Companies such as Nielsen BioSciences, Inc, TEVA PHARMACEUTICAL INDUSTRIES LTD amongst others are some of the companies that have been implementing various organic strategies that have helped the growth of the company.
The factors that are driving growth of the market are rising prevalence of human papillomavirus infections and recurrence of genital warts and new product developments.
Warts are skin growth caused by the human papillomavirus (HPV). There are more than 60 types of HPV, some of which tend to cause warts on the skin. Topical treatments could probably resolve the issue of warts in a few weeks with minimal side effects. Topical treatment of may not be effective all the time. Hence, cryotherapy with liquid nitrogen is a suitable option for treatment, where cure rate is 60% to 90% with less than 20% to 10% recurrence rate.
Trends and growth analysis reports related to Life Sciences : READ MORE..
The List of Companies - Warts Therapeutics Market
- Bausch Health Companies Inc.
- Nielsen BioSciences, Inc.
- Euro Vital Pharma GmbH
- Cipla Inc.
- Koninklijke Utermöhlen NV
- Novan, Inc.
- Scholl's Wellness Company
- TEVA PHARMACEUTICAL INDUSTRIES LTD
- Verrica Pharmaceuticals Inc.
- GlaxoSmithKline plc.
- AIM ImmunoTech Inc
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.